Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Liver Neoplasms × Lamivudine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3 Recurrence 2 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Liver Neoplasms 1 Hepatitis B 1

Interventions

Sorafenib 7 Oxaliplatin 7 Fluorouracil 6 Radiofrequency Ablation 5 Neoadjuvant Therapy 5 lenvatinib 4 Injections 4 Doxorubicin 4 Chemotherapy, Adjuvant 4 toripalimab 3 pembrolizumab 3 Ultrasonography 3 Leucovorin 3 Irinotecan 3 Cisplatin 3 tislelizumab 2 sintilimab 2 durvalumab 2 camrelizumab 2 anlotinib 2 Walking Speed 2 Standard of Care 2 Oncolytic Virotherapy 2 Liver Transplantation 2 Immunohistochemistry 2 High-Energy Shock Waves 2 Gemcitabine 2 Cyclophosphamide 2 Biopsy 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00555334 2009-04-01

LAM-RFA

Sun Yat-sen University

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡